Document is current
Any future updates will be listed below
-
Authors
Veletic, Ivo https://orcid.org/0000-0001-5802-5313
Harris, David M.
Rozovski, Uri
Bertilaccio, Maria Teresa S. https://orcid.org/0000-0002-2304-4618
Calin, George A. https://orcid.org/0000-0002-7427-0578
Takahashi, Koichi https://orcid.org/0000-0002-8027-9659
Li, Ping
Liu, Zhiming
Manshouri, Taghi
Drula, Rares-Constantin
Furudate, Ken https://orcid.org/0000-0003-1272-5490
Muftuoglu, Muharrem https://orcid.org/0000-0001-8100-8554
Hossain, Anwar
Wierda, William G. https://orcid.org/0000-0002-7357-270X
Keating, Michael J.
Estrov, Zeev https://orcid.org/0000-0002-1623-3613
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
CLL Global Research Foundation
- License Information
-
More Information
Article History
Received: 12 October 2024
Revised: 11 March 2025
Accepted: 25 March 2025
First Online: 4 April 2025
Competing interests
: The authors declare no competing interests.
: All procedures involving human participants were conducted in accordance with institutional guidelines, U.S. federal and state regulations, and the ethical standards laid down in the Declaration of Helsinki. Ethical approval was obtained from the Institutional Review Board of The University of Texas MD Anderson Cancer Center (IRB Registration Number: IRB00000121). Written informed consent was obtained from all participants for the use of anonymized data and biological specimens for research purposes.
